Download the full announcement
EKF Diagnostics Holdings plc (AIM: EKF), the AIM quoted medical diagnostics business, announces that at the General Meeting held earlier today, the resolution to approve a distribution of the Company's shareholding in Renalytix AI plc to the Company's shareholders was duly passed. This enables the Directors to proceed to finalise the necessary arrangements to give effect to the distribution.
Further announcements will be made in due course.
EKF Diagnostics Holdings plc
Christopher Mills, Non-Executive Chairman
Julian Baines, CEO
Richard Evans, FD and COO
Tel: 00 44 29 2071 0570
|N+1 Singer (Nomad & Broker)
Aubrey Powell / Lauren Kettle / George Tzimas
|Tel: 020 7496 3000
Walbrook PR Limited
|Tel: 020 7933 8780 or
Mob: 07980 541 893 / 07584 391 303